Low
₹
High
₹
| Previous Close | ₹72.00 |
|---|---|
| Day's Range | ₹70.00 - ₹72.00 |
| Open | ₹70.00 |
| 52 Week Range | ₹44.83 - ₹118.65 |
| Volume | 526 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 0.38 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -2.46 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 3.09 |
| PAT Margin (%) | -15.20 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -24.62 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 44.03 | 215.64 |
| Expenses | N/A | N/A |
| PBT | -23.64 | -32.77 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -23.64 | -32.77 |
| Founded | 1994 |
|---|---|
| Managing Director | Shailesh J Shah |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Hindustan Unilever Ltd. | 5,05,420.58 | 2,122.90 | 2,022.50 - 2,022.50 |
| ITC Ltd. | 3,64,356.94 | 286.50 | 275.05 - 275.05 |
| Nestle India Ltd. | 2,67,476.48 | 1,400.50 | 1,084.70 - 1,084.70 |
| Varun Beverages Ltd. | 1,70,586.11 | 505.30 | 381.00 - 381.00 |
| Britannia Industries Ltd. | 1,22,952.43 | 5,128.75 | 5,035.00 - 5,035.00 |
| Marico Ltd. | 1,09,064.46 | 834.45 | 690.20 - 690.20 |
| Godrej Consumer Products Ltd. | 1,04,514.20 | 1,009.25 | 967.05 - 967.05 |
| Dabur India Ltd. | 75,605.85 | 423.80 | 403.35 - 403.35 |
| Colgate-Palmolive (India) Ltd. | 54,363.13 | 1,993.00 | 1,782.00 - 1,782.00 |
| Patanjali Foods Ltd. | 44,895.36 | 408.85 | 407.50 - 407.50 |
No Records Found
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s code of conduct for regulating, monitoring, and reporting of trading by insiders, KSE has informed that the Trading Window for trading/dealing in Shares of the Company will remain closed from July 1, 2026 until 48 hours after declaration of Unaudited financial results of the Company for the Quarter ending on 30th June, 2026. During the closure of trading window, all designated persons of the Company (including their immediate relatives) have been advised not to deal in the Shares of the Company. The date of the Board Meeting of the Company for declaration of Unaudited Financial Results for the Quarter year ended 30th June, 2026, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Pursuant to the provisions of Regulation 30 of the Listing Regulations, KSE has informed that Umkal Health Care, a wholly owned subsidiary of the Company has today approved the expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, with the addition of 100 new beds. The newly expanded facility will be branded as Park Hospital Platinum and is expected to commence its operation in November, 2026. The press release towards the aforesaid expansion is also enclosed. The details, as required under the Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in ‘Annexure’ as enclosed. The disclosure is also being disseminated on the Company's website at https://www.parkhospital.in/.
The above information is a part of company’s filings submitted to BSE.
Further to its letter dated 24th June, 2026, regarding schedule of an in-person Investor Roadshow of Investor Meetings to be held on 29th June, 2026 & 30th June, 2026 in Mumbai, Uflex has informed that it enclosed a copy of the Investor Presentation which will be shared to the Investor(s) in the said Meeting(s). Further, no unpublished price sensitive information will be shared during the said Investor Meetings.
The above information is a part of company’s filings submitted to BSE.
SKM Egg Products Export (India) has informed that as per the Company's Code of Conduct for trading in Listed Securities, the trading window for dealing in the securities of the Company shall remain closed for all Directors/connected persons/Designated persons of the Company from 01st July, 2026 till 48 hours after the announcement of unaudited financial results of the Company for the quarter ended 30th June, 2026 to the Public. Accordingly, all Directors/connected Persons/Designated Persons of the Company are advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Hipolin Ltd. is ₹72.00 as of 2026-06-30.
The market capitalisation of Hipolin Ltd. is ₹22.86 as of 2026-06-29.
The 1-year return of Hipolin Ltd. is 1.05% as of 2025-06-27.
The P/E ratio of Hipolin Ltd. is 0.00 as of 2026-06-30.
The 52-week high and low of Hipolin Ltd. are ₹118.65 and ₹44.83, respectively, as of 2026-06-30.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.